Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1998-8-12
pubmed:abstractText
To retrospectively construct a comprehensive multivariate model of cancer recurrence and to design a molecular pathologic substaging system in stage I non-small-cell lung cancer (NSCLC).
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2468-77
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:9667266-Adult, pubmed-meshheading:9667266-Aged, pubmed-meshheading:9667266-Aged, 80 and over, pubmed-meshheading:9667266-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:9667266-DNA Primers, pubmed-meshheading:9667266-Female, pubmed-meshheading:9667266-Genes, ras, pubmed-meshheading:9667266-Humans, pubmed-meshheading:9667266-Karnofsky Performance Status, pubmed-meshheading:9667266-Lung Neoplasms, pubmed-meshheading:9667266-Lymphatic Metastasis, pubmed-meshheading:9667266-Male, pubmed-meshheading:9667266-Middle Aged, pubmed-meshheading:9667266-Mutation, pubmed-meshheading:9667266-Neoplasm Staging, pubmed-meshheading:9667266-Predictive Value of Tests, pubmed-meshheading:9667266-Prognosis, pubmed-meshheading:9667266-Prospective Studies, pubmed-meshheading:9667266-Retrospective Studies, pubmed-meshheading:9667266-Risk Factors, pubmed-meshheading:9667266-Survival Analysis, pubmed-meshheading:9667266-Treatment Outcome
pubmed:year
1998
pubmed:articleTitle
Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.
pubmed:affiliation
Division of Experimental Medicine, Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA. kwiatkowski@calvin.bwh.harvard.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't